Considered and approved Standalone and Consolidated Financial Results for the half year and year ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shivam Chemicals Limited (SME-listed on BSE in April 2024) reported its first full-year audited results since listing. Consolidated revenue from operations rose about 53% to Rs 22,413.34 lakhs (from Rs 14,654.11 lakhs in FY24), while consolidated profit after tax jumped to Rs 209.30 lakhs from Rs 120.65 lakhs, an increase of around 73%. Standalone revenue grew to Rs 20,736.05 lakhs and standalone PAT to Rs 257.14 lakhs (from Rs 200.64 lakhs). Basic EPS on a consolidated basis improved to Rs 1.26 from Rs 0.97. The statutory auditors (PSRD & Co.) issued an unmodified (clean) opinion on both standalone and consolidated results.
Strong top-line growth and decent profit expansion signal healthy business momentum post-listing, which is positive for shareholders. However, operating cash flow turned sharply negative (Rs 1,461 lakhs consolidated vs Rs 495 lakhs positive last year) due to a big jump in receivables and inventories, which investors should monitor as it points to working-capital strain even as reported profits grew.